News Quebec becomes the first province to fund GAZYVA for CLL patients People in Quebec living with Chronic Lymphocytic Leukemia (CLL) will now be able to access…adminJune 4, 2015
News Get healthy, get happy and make a difference! Join Lymphoma Canada for a day of wellness. Lymphoma Canada is ready to stretch, breath…adminJune 1, 2015
NewsResearch 2013 Research Fellowship – Progress Update Burkitt’s lymphoma (BL) is a type of non-Hodgkin lymphoma. It is characterized by a mutation…adminJune 1, 2015
News Managing the Side Effects of Chemotherapy Managing the Side Effects of Chemotherapy In collaboration with Colorectal Cancer Association of Canada and…adminMay 27, 2015
News CANO Award of Excellence in Honour of the Heos Family This award recognizes a CANO/ACIO member whose actions support the concept of patient advocacy and…adminMay 25, 2015
News Life Beyond Lymphoma Portal Lymphoma Canada has created a personalized portal with resources tailored to the off-treatment phases of…adminMay 15, 2015
News CanCertainty for All: Cancer’s Not Fair, But Accessing Treatment Should Be The CanCertainty Coalition, a collaboration of 35 cancer patient groups, physicians and national healthcare charities…adminMay 7, 2015
News pERC Initial Recommendations Issued for Romidepsin (Istodax) On April 30, 2015, the pCODR Expert Review Committee (pERC) issued initial recommendations for Romidepsin…adminMay 1, 2015
News Health Canada approves Zydelig in CLL and Follicular lymphomas Health Canada approves ZYDELIG™ (idelalisib) for treatment of relapsed chronic lymphocyctic leukemia and conditionally approves…adminApril 28, 2015
News CLL patients with idelalisib (Zydelig) experience Lymphoma Canada is conducting a survey of CLL patients with experience with idelalisib (Zydelig) to…adminMarch 16, 2015